Most Read Articles
Elvira Manzano, one year ago
Switching to esomeprazole improves reflux symptoms and quality of life (QoL) in Japanese patients with gastroesophageal reflux disease (GERD) who are refractory to conventional proton pump inhibitors (PPIs), a Japanese study has shown.
one year ago
Public awareness of the specific alarm symptoms of upper gastrointestinal (GI) cancer are not very prevalent, and healthcare-seeking behaviour regarding the disease remains poor, according to a recent study.
Kathlin Ambrose, one year ago
Microbes are strongly associated with metabolic syndrome. Conversely, however, the microbiome also potentially holds the key to health solutions, says an expert.
one year ago
Saccharomyces boulardii aids in lowering Helicobacter pylori colonisation in the gastrointestinal system of asymptomatic primary school children, as reported in a randomised, double-blind, placebo-controlled clinical trial.

Case studies: Hepatorenal syndrome

5 months ago
An expert panel meeting on hepatorenal syndrome (HRS) was recently convened in Kuala Lumpur with the aim of discussing management practices in different hospital settings. Chaired by Professor Sanjiv Mahadeva, consultant gastroenterologist, University Malaya Medical Centre, the meeting saw local and regional experts share HRS cases they have encountered in their practice.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
Elvira Manzano, one year ago
Switching to esomeprazole improves reflux symptoms and quality of life (QoL) in Japanese patients with gastroesophageal reflux disease (GERD) who are refractory to conventional proton pump inhibitors (PPIs), a Japanese study has shown.
one year ago
Public awareness of the specific alarm symptoms of upper gastrointestinal (GI) cancer are not very prevalent, and healthcare-seeking behaviour regarding the disease remains poor, according to a recent study.
Kathlin Ambrose, one year ago
Microbes are strongly associated with metabolic syndrome. Conversely, however, the microbiome also potentially holds the key to health solutions, says an expert.
one year ago
Saccharomyces boulardii aids in lowering Helicobacter pylori colonisation in the gastrointestinal system of asymptomatic primary school children, as reported in a randomised, double-blind, placebo-controlled clinical trial.